These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27462870)

  • 21. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
    González-Álvaro I; Martínez-Fernández C; Dorantes-Calderón B; García-Vicuña R; Hernández-Cruz B; Herrero-Ambrosio A; Ibarra-Barrueta O; Martín-Mola E; Monte-Boquet E; Morell-Baladrón A; Sanmartí R; Sanz-Sanz J; de Toro-Santos FJ; Vela P; Román Ivorra JA; Poveda-Andrés JL; Muñoz-Fernández S; ;
    Rheumatology (Oxford); 2015 Jul; 54(7):1200-9. PubMed ID: 25526976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Saudi consensus recommendations for the management of psoriatic arthritis (2023).
    Al-Homood IA; Al Ghanim N; Fatani MIA; Hussein AH; Alolaiwi AM; Abualiat A; Alqurtas E; Alomari BAA; Khardaly AM; Alenzi KAO; Albarakati RG; Almudaiheem HY; Al-Jedai A; Eshmawi MTY
    Clin Rheumatol; 2024 Mar; 43(3):879-894. PubMed ID: 38217738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of systemic glucocorticoids in patients with psoriatic arthritis by Argentinian and other Latin-American rheumatologists.
    Aimo C; Cosentino VL; Sequeira G; Kerzberg E
    Rheumatol Int; 2019 Apr; 39(4):723-727. PubMed ID: 30830285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
    Singh JA; Guyatt G; Ogdie A; Gladman DD; Deal C; Deodhar A; Dubreuil M; Dunham J; Husni ME; Kenny S; Kwan-Morley J; Lin J; Marchetta P; Mease PJ; Merola JF; Miner J; Ritchlin CT; Siaton B; Smith BJ; Van Voorhees AS; Jonsson AH; Shah AA; Sullivan N; Turgunbaev M; Coates LC; Gottlieb A; Magrey M; Nowell WB; Orbai AM; Reddy SM; Scher JU; Siegel E; Siegel M; Walsh JA; Turner AS; Reston J
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):2-29. PubMed ID: 30499259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriatic arthritis: new evidence for old concepts.
    Soriano ER; Marin J; Acosta-Felquer ML
    Curr Opin Rheumatol; 2018 Jan; 30(1):87-93. PubMed ID: 29035933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard".
    Symmons DP; Lunt M; Watkins G; Helliwell P; Jones S; McHugh N; Veale D
    J Rheumatol; 2006 Mar; 33(3):552-7. PubMed ID: 16463433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from Japan.
    Okada M; Kurimoto S; Ganz F; Boehncke WH
    PLoS One; 2021; 16(1):e0245954. PubMed ID: 33503031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriatic arthritis: current therapy and future approaches.
    Huynh D; Kavanaugh A
    Rheumatology (Oxford); 2015 Jan; 54(1):20-8. PubMed ID: 25125588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis.
    Salvarani C; Girolomoni G; Di Lernia V; Gisondi P; Tripepi G; Egan CG; Marchesoni A;
    Semin Arthritis Rheum; 2016 Dec; 46(3):305-311. PubMed ID: 27470190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of disease activity measures for psoriatic arthritis: what is the best approach?
    Her M; Kavanaugh A
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1241-54. PubMed ID: 25088300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process.
    García-Vicuña R; Garrido N; Gómez S; Joven B; Queiro R; Ramírez J; Rebollo F; Loza E; Sellas A
    Rheumatol Int; 2021 Sep; 41(9):1549-1565. PubMed ID: 33934175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting.
    Cauli A; Lubrano E; Scarpa R; Olivieri I
    J Rheumatol; 2012 Nov; 39(11):2201-3. PubMed ID: 23118288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists.
    Gottlieb AB; Wells AF; Merola JF
    Clin Rheumatol; 2022 May; 41(5):1271-1283. PubMed ID: 35083564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriatic arthritis assessment and treatment update.
    Mease PJ
    Curr Opin Rheumatol; 2009 Jul; 21(4):348-55. PubMed ID: 19461518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
    Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
    Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritis.
    Dures E; Taylor J; Shepperd S; Mukherjee S; Robson J; Vlaev I; Walsh N; Coates LC
    Ann Rheum Dis; 2020 Aug; 79(8):1031-1036. PubMed ID: 32424031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis.
    Kalkan A; Hallert E; Carlsson P; Roback K; Sjöwall C
    Scand J Rheumatol; 2015; 44(4):265-70. PubMed ID: 26202443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
    López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C;
    Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
    Tillett W; Allen A; Tucker L; Chandler D; Ciurtin C; Davis C; Dick A; Foulkes A; Gullick N; Helliwell P; Jadon D; Jones G; Kyle S; Madhok V; McHugh N; Parkinson A; Raine T; Siebert S; Smith C; Coates LC
    Rheumatology (Oxford); 2021 Apr; 60(4):1588-1592. PubMed ID: 33097948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.